This changes everything.

DeepWell DTx has opened a significant new revenue stream for media makers by creating a reimbursable immersive medicine market. This is a moonshot opportunity blending powerful media into digital therapeutics that effectively targets the global mental health crisis.

We know art can be medicine and experiencing immersive art may have transformative qualities. DeepWell’s technology allows for immersive experiences to be legitimized and reimbursed for the healing value it brings.

As designers we know how to get the attention and hold the attention, and now we are going to be able to convert these to FDA cleared therapeutics.

DeepWell is an important innovation in a world where accessible therapies for mental health concerns are desperately needed. I'm excited to see what's next.

Since the pioneering days of VR, this is where we always knew the medium was capable of going. With DeepWell's FDA clearance there is no turning back now as immersive media becomes immersive medicine.

We are starting at the foundation with good game mechanics and sound game design, with that we are building out medical treatments that have been proven to work.

In the 20th century, healthcare was largely driven by advancement in pharmaceuticals. For the next hundred years, it will be driven by technology. DeepWell's FDA clearance puts them at the cutting edge of this emerging revolution.

What DeepWell has accomplished in connection with the work the Digital Therapy Alliance has done to lobby congress and secure reimbursement will bring mental health support to millions of American families.

The recognition of the medical value of media and creation of the Immersive Medicine signals a significant advancement in non-invasive neurostimulation, effective therapeutic delivery and a new paradigm in digital therapeutics.

I expect DeepWell’s technology and treatment approach to change how we design therapeutics for a wide range of neurological conditions.

The convergence of Interactive and Immersive Systems, Artificial Intelligence, and Biosensing Technologies is poised to impact healthcare positively. This clears the pathway for developing enhanced methods of clinical care and broader access to personalized care.

DeepWell's work and landmark FDA clearance opens the door to the first para-psychadelic assisted digital therapeutics.

Games allow us to tap into the dopaminergic and serotonergic networks to open the patient up to think and behave in a different way.

DeepWell’s ABS system will power a whole generation of video game therapeutics for mental and physical therapists to use.

It has been a fundamental challenge in medicine to get patients to want to engage, to do the work and get better. This approach moves us from asking for compliance to becoming compelling.